Fifth Third Bancorp
ADMA icon

Fifth Third Bancorp’s ADMA Biologics ADMA Stock Holding History

Fifth Third Bancorp’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$500K Buy
55,508
+54,803
+7,773% +$865K ﹤0.01% 2043
2025
Q4 		$12.9K Sell
705
-371
-34% -$6.25K ﹤0.01% 2055
2025
Q3 		$15.8K Sell
1,076
-66
-6% -$1.13K ﹤0.01% 1985
2025
Q2 		$20.8K Buy
1,142
+27
+2% +$551 ﹤0.01% 1764
2025
Q1 		$22.1K Buy
1,115
+672
+152% +$11.6K ﹤0.01% 1722
2024
Q4 		$7.6K Buy
443
+129
+41% +$2.43K ﹤0.01% 2051
2024
Q3 		$6.28K Buy
+314
New +$4.88K ﹤0.01% 2127

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fifth Third Bancorp's ADMA Position: Q1 2026 in Review

Fifth Third Bancorp increased its ADMA Biologics (ADMA) stake by 7,773% in Q1 2026, buying an estimated $865K and bringing the position to 55,508 shares worth $500K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

Fifth Third Bancorp first reported a position in ADMA in Q3 2024 and has held it in 7 quarters since. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Fifth Third Bancorp held 55,508 shares of ADMA Biologics worth $500K as of Q1 2026.
  • Fifth Third Bancorp bought 54,803 ADMA Biologics shares in Q1 2026, an estimated $865K.
  • ADMA Biologics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2043 holding.
  • Fifth Third Bancorp first reported a position in ADMA Biologics in Q3 2024 and has held it in 7 quarters since.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.